Author: Lilly Matson

Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.

You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons.

Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.

Our researchers across the world are investigating a potential link between bowel cancer and the microbiome, and the potential role antibiotics might play.

This week, NHS England has proposed a shift in new standards for cancer care and waiting times, with an emphasis on a more recently introduced measure, called the ‘Faster Diagnosis Standard (FDS).

“Our motivation for studying it is because there haven’t been any new effective treatments for decades.” Overall, survival for children’s…

A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic.

Recently, news of a COVID-19 vaccine has dominated headlines. We’ve summarised all the information that is out there, with rolling updates, in our new vaccine blog post.

Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms.

New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways.